Aortech Share Discussion Threads

[gac141] 28/8/2013 11:28

Hi David

I think your not correct but happy to see what the next month brings...

[cocker] 28/8/2013 11:20

As long as shareholders who own 1% or more see progress what hope is there. Next months court case is far from a cert and lets be fair, who will pay top dollar for a company who is on its knees. I can see aor drifting along for some time with little reward for those already on board

[gac141] 28/8/2013 10:15

I think all in all from where we were a year ago this is a fair result..If we see concrete orders near term the share price will take care of itself.

We need the directors to remain fully focused and diligent in running this business as there is no doubt the past performance pre 12 months was very poor and this is what led to loose cannons firing off and diabolical business decisions being made.The eye historically was well and truly off the ball.

I am encouraged that existing but more up-to-date deals may come through and hit the bottom line...Maybe at that point the business may find itself being stalked by a larger predator.

[landy90] 28/8/2013 09:53

Given the last 12 months, it is clear the share price was wrong this time last year, the board are now talking about profitability and there will not be the drag of the sub scale manufacturing plant so the current value may well prove to be wrong and the value last year better judged.
Timing of judging it? Shorter term than you might think, with the new business model, there is no where to hide!

[harrogate] 28/8/2013 09:36

Agreed but the question is is the company worth more than the current share price and it could be a long time before we can answer that question.

[landy90] 28/8/2013 09:23

I think they pretty much said no sale in the May update. Given the hand that they were holding 12 months ago, the turn around is pretty good.

[harrogate] 28/8/2013 09:14

Yes but no sale or capital sum coming our way and so we are now in this for the long haul. Let's hope newsflow and licence revenue increases are enough to get the share price up a few pence at sometime so I can get out .. ca't really see why anyone would wnat to hold except the fact that they can't sell to anyone.

[landy90] 28/8/2013 09:10

The key extracts from the Chairmans statement as I see it

"Your Board is now pursuing a strategy to exploit the value of the Company's IP, Patents and know-how without the problems of having to operate a sub-scale manufacturing facility. It is our intention to fully transition AorTech to an IP business......AorTech is presently in discussions with a well respected, mid-sized US polymer and medical device component manufacturer, with the intention of concluding a contract for the manufacture of AorTech's polymers. Under such an arrangement the income generated by AorTech would arise from revenue share from manufacturing activities together with licence fees......As part of the licence agreement to manufacture, our IP and know-how will be protected, which should extend the value of our licence agreements beyond any patent expiry date.

The potential income forecast by the licensees could result in significant royalties

This strategy and business model allows the annual operating costs of AorTech to be kept to a minimum, provides a supply of material to existing customers and enables the Group to benefit not only from its future royalty stream but also potentially to share in the value of new business generated by our manufacturing licensee.


Your Board has strived to implement a strategy which will enable the Group to achieve both growth and profitability to enhance shareholder value. We believe that we have now established the appropriate business model to deliver not only a profitable business but also one that can be done at attractive net margins without the requirement to raise further capital from shareholders."

So.. costs cut, cash ok, no need for money from shareholders, licenses manufacturing to someone who will hopefully promote product better than we did, we get paid a share of revenues (better than the loss we made on supply) and royalty income to increase over next few years.

[landy90] 22/8/2013 10:54

Aortech is due to announce results soon, I expect they will include a detailed update in the report.

[harrogate] 22/8/2013 07:56

There is no doubt that somehting needs to be said by way of an update .. Sometimes if discussions are ongoing but not finalised it is hard ...let's hope this is the case here. Hard to be too optimistic given the last 8 months though

[gac141] 21/8/2013 19:20

Let's see what they have to say. I think some sort of update is due..

[gac141] 12/8/2013 09:07

Have we got ourselves a new market maker...Interesting...

[cocker] 10/8/2013 11:45

The low volume is because no one wants to buy the stock. However, 16k when there is 4.83million shares in circulation is hardly a positive sign. It could well be mm's trying to fool punters into buying the stock as they may have a seller in their mists.

[papillon88] 09/8/2013 21:43

If u compare daily vol over the last few months 16k seems exceptional

[cocker] 09/8/2013 19:52

16k is hardly decent volume. However , any rise is very welcome & only another £ 1.30 to break even for yours truely

[papillon88] 09/8/2013 16:18

22% rise today with decent vol traded.
very quiet on here.
Will be interesting to see what's behind today's rise

[gac141] 08/8/2013 13:22

There is no doubt that communication here is dire..Much promised very little delivered.. Frank shoulders much of that .. I HOPE that we are working on our future.....

[1400] 08/8/2013 12:37

Since when did we ever follow up with any lincensee? The MO here has always been sign and forget it and maybe everybody else will.

Sorry George,but that's the way these people have got to me. Hopefully you are right and we might be involved.

[gac141] 08/8/2013 10:42

Does this have an impact on us... If so why have we not heard anything?

[gac141] 01/8/2013 22:23

St. Jude Medical introduces wireless MRI-conditional pacemaker in Japan
St. Paul, Minnesota

We may have seen this before but cant remember..


St. Jude Medical, Inc., a global medical device company, has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to launch the Accent MRI Pacemaker and the Tendril MRI lead. Unlike MRI-labeled devices currently available, the Accent MRI pacemaker is the only commercially available system with labeling that allows patients to undergo full-body, high-resolution magnetic resonance imaging (MRI) scans to accommodate their current and future medical needs.

Commenting on the Accent MRI pacemaker, Dr Toshiko Nakai, assistant professor of the Nihon University School of Medicine in Tokyo said, "We are pleased to see the MRI-conditional pacemaker launched by St. Jude Medical. I believe the benefit of full-body scanning with 1.5 Tesla MRI, the 6 millimeter thinness and ability to provide remote monitoring together make this device patient-friendly."

MRI scans are important imaging procedures as they better evaluate the presence of certain diseases and injuries that may not be adequately assessed with other imaging methods, such as X-ray or ultrasound. Patients with traditional pacing systems are discouraged from receiving MRI scans because their device may be affected, which deprives them the standard of care MRI diagnostic technology provides.

"The Accent MRI pacemaker has many advantages over what is currently available for patients. The sophisticated pacemaker functionality and labeling of full-body MRI scans are especially important for patients who may need an MRI scan in the chest and abdominal area. We are excited to offer this innovative technology to hospitals throughout Japan," said William Phillips, senior vice president of St. Jude Medical Asia.

The system features an MRI Activator device that provides a simple option for programming the patient's pacemaker to the appropriate MRI mode for use during the MRI scan. The press of a single button on the handheld MRI Activator device can program the specific device parameters to be used during the MRI scan. These parameters are pre-selected by the patient's physician and stored in the memory of the Accent MRI pacemaker. The MRI Activator can then programme the device back to its original parameters after the scan has been completed.

Built on the proven Tendril lead platform, the pacing lead offers unique capabilities for safe, full power MRI scanning, including 6F proximal lead body diameter and excellent handling characteristics. The lead features Optim lead insulation, the first silicone-polyurethane, co-polymer material created specifically for cardiac lead use. The Optim insulation is designed for long-term reliability, while providing physicians with better flexibility and handling to facilitate device implantation.

[papillon88] 01/8/2013 21:30

I guess some consolation now is that we can only go down by another 38p

[papillon88] 30/7/2013 11:14

It seems even the ultimate optimist GAC has given up on this one.
Bless him